RFA
GILD icon

Resurgent Financial Advisors’s Gilead Sciences GILD Stock Holding History

Resurgent Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+1,763
New +$232K 0.06% 276
2024
Q1 		– Sell
-2,407
Closed -$195K – 297
2023
Q4 		$195K Buy
2,407
+263
+12% +$20.5K 0.12% 169
2023
Q3 		$161K Buy
2,144
+79
+4% +$6.08K 0.11% 169
2023
Q2 		$159K Sell
2,065
-48
-2% -$3.83K 0.11% 174
2023
Q1 		$175K Sell
2,113
-2,115
-50% -$175K 0.12% 163
2022
Q4 		$363K Sell
4,228
-235
-5% -$18.6K 0.19% 122
2022
Q3 		$276K Buy
4,463
+1,149
+35% +$72.5K 0.18% 143
2022
Q2 		$205K Sell
3,314
-1,559
-32% -$96.5K 0.13% 175
2022
Q1 		$289K Buy
+4,873
New +$311K 0.18% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Resurgent Financial Advisors's GILD Position: Q2 2026 in Review

Resurgent Financial Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,763 shares worth $223K. The stake represents 0.06% of the portfolio and ranks #276 among its holdings. This is a return to the name: Resurgent Financial Advisors previously reported a position in GILD as recently as Q4 2023.

Resurgent Financial Advisors first reported a position in GILD in Q1 2022 and has held it in 9 quarters since. The position peaked at $363K in Q4 2022. 2,292 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Resurgent Financial Advisors held 1,763 shares of Gilead Sciences worth $223K as of Q2 2026.
  • Gilead Sciences was a new Resurgent Financial Advisors position in Q2 2026.
  • Gilead Sciences made up 0.06% of Resurgent Financial Advisors's portfolio in Q2 2026, its #276 holding.
  • Resurgent Financial Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 9 quarters since.
  • Resurgent Financial Advisors's Gilead Sciences position peaked at $363K in Q4 2022.
  • 2,292 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Resurgent Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.